| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.52 | 0.0005 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0005 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0009 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |